These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 3458017)

  • 21. [Value of CA 19-9 in tumor after-care in stomach and colorectal cancer].
    Safi F; Rappenecker B; Roscher R; Beger HG
    Med Klin (Munich); 1986 Jan; 81(1):12-4. PubMed ID: 3466002
    [No Abstract]   [Full Text] [Related]  

  • 22. [CA 125 and CA 19-9 in non-Hodgkin's lymphomas].
    Buhl C; Füllbrandt U; Pompecki R; Frenzel H
    Dtsch Med Wochenschr; 1986 Jun; 111(23):921-2. PubMed ID: 3458585
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical evaluation of a cancer antigen, CA 125, associated with ovarian cancer. I. Technical investigation and the reference value].
    Sakurabayashi I; Kawai T; Suzuki M; Tamada T; Sato K; Yonezawa M
    Rinsho Byori; 1984 Dec; 32(12):1345-9. PubMed ID: 6597875
    [No Abstract]   [Full Text] [Related]  

  • 24. [Tumor markers in the diagnosis of tumors in the subhepatic area].
    Dufek V; Petrtýl J; Klener P; Chmel J
    Vnitr Lek; 1994 Jun; 40(6):350-3. PubMed ID: 8073643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Behavior of CA 19-9 in benign pathology of the gastrointestinal tract. Preliminary data].
    Magri GC; Maculotti L; Vigorelli R
    Minerva Chir; 1987 May; 42(10):901-3. PubMed ID: 3476862
    [No Abstract]   [Full Text] [Related]  

  • 26. [Serum levels of the CA-125 antigen in the diagnosis of ovarian neoplasms].
    Sopracordevole F; Finco B; Scarabelli C; Campagnutta E; Alimena C; Perin A
    Minerva Ginecol; 1985 Oct; 37(10):589-96. PubMed ID: 3866146
    [No Abstract]   [Full Text] [Related]  

  • 27. [Ca 12-5 in stomach and colorectal cancer. A comparison with the tumor markers CEA and Ca 19-9].
    Quentmeier A; Schlag P; Geisen HP; Schmidt-Gayk H
    Med Klin (Munich); 1986 Mar; 81(6):199-201. PubMed ID: 3466003
    [No Abstract]   [Full Text] [Related]  

  • 28. [Correlation of histopathology and application of CA 19/9 monoclonal antibodies in the diagnosis of Vater's ampulla epithelial neoplasms].
    Chimicata S; Caruso R; Pellicanò G; Inferrera C
    Pathologica; 1987; 79(1062):427-36. PubMed ID: 3482711
    [No Abstract]   [Full Text] [Related]  

  • 29. Analysis of the prognostic significance of cytosolic determination of CA 125 tumor-associated antigen, carcinoembryonic antigen and squamous cell carcinoma antigen in patients with nonsmall cell lung carcinoma.
    Picardo AL; Diez M; Torres A; Maestro M; Ortega D; Hernando F; Gómez A; Garcia-Asenjo J; Balibrea JL
    Cancer; 1996 Mar; 77(6):1066-72. PubMed ID: 8635125
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum levels of the carbohydrate antigen CA-50 in pancreatic disease.
    Blind PJ; Dahlgren ST
    Acta Chir Scand; 1987 Jan; 153(1):45-9. PubMed ID: 3472420
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Usefulness of CA.125 as a co-adjuvant test in the diagnosis and follow-up of ovarian cancer].
    Hernández Briz MJ; Díaz Redondo A; Mújica Menéndez I; Merino Ramírez J; Crespo Azanza E; Fernández Villoria E; Sánchez Martín JA
    Rev Clin Esp; 1986 Oct; 179(5):240-2. PubMed ID: 3466260
    [No Abstract]   [Full Text] [Related]  

  • 32. [CA-50: evaluation of a new tumor marker in the diagnosis of neoplastic pathologies of the gastrointestinal tract].
    Pecchio F; Ricci E; Rapellino M; Oliaro A; Adamo MR; Marzola G; Piantino P
    Minerva Med; 1987 Feb; 78(3):141-4. PubMed ID: 3469541
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Assay of CA 19-9 in cancer of the pancreas: preliminary results].
    Gosselin P; Besson P; Demaille MC; Sulman C
    LARC Med; 1984; 4(6):383. PubMed ID: 6590940
    [No Abstract]   [Full Text] [Related]  

  • 34. [CA125 in patients with pleural effusion--in comparison with ascites patients].
    Kawabe T; Hirano M; Mohri M; Sugimoto T; Nagata Y; Hisada M; Muto H; Unuma T; Momose T; Naka H
    Rinsho Byori; 1987 Aug; 35(8):905-9. PubMed ID: 3480365
    [No Abstract]   [Full Text] [Related]  

  • 35. [Tumor markers in the diagnosis and prognosis of breast cancer].
    Seliuzhitskiĭ IV; Skvortsov SV; Lytsar BN; Khomenko LP
    Klin Med (Mosk); 1993; 71(2):25-7. PubMed ID: 8046917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of CA 72-4 as a new tumor marker in patients with gastric cancer.
    Goral V; Yesilbagdan H; Kaplan A; Sit D
    Hepatogastroenterology; 2007 Jun; 54(76):1272-5. PubMed ID: 17629087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictive value of CA 125 for ovarian carcinoma in patients presenting with pelvic masses.
    O'Connell GJ; Ryan E; Murphy KJ; Prefontaine M
    Obstet Gynecol; 1987 Dec; 70(6):930-2. PubMed ID: 3479735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [CEA, CA 19.9 and CA 195 in patients with colorectal carcinoma. ROC analysis].
    Vallejo J; Torres-Avisbal M; Contreras P; Rodríguez-Liñán M; Rebollo A; González F; Benítez A; Infante J; Mateo A
    Rev Esp Med Nucl; 1999 Aug; 18(4):281-6. PubMed ID: 10481111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Diagnosis of pancreatic carcinoma using 2 associated monoclonal antibodies].
    Yao CZ; Zeng XJ; Wang SZ
    Zhonghua Wai Ke Za Zhi; 1987 Nov; 25(11):655-8, 670. PubMed ID: 3482539
    [No Abstract]   [Full Text] [Related]  

  • 40. [Incidence of CA 125 antigen in the blood of women with ovarian carcinoma].
    Tosner J; Lacinová V; Louda B; Vanásek J
    Cesk Gynekol; 1987 Nov; 52(9):681-4. PubMed ID: 3482173
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.